Osmind News

Osmind Collaborates with Compass Pathways to Advance Independent Clinic Readiness for Psychedelic Treatments

April 21, 2026

Osmind and CareNet GPO partner to make next-gen psychiatric treatments accessible and sustainable to independent psychiatry practices nationwide

April 9, 2026

Osmind partners with LivaNova to Support Education and Awareness for Clinicians Caring for People Living with Difficult-to-treat Depression

February 9, 2026

Bendable Therapy and Osmind to Present First Real-World Outcomes Data from Legal U.S. Psilocybin Services

September 16, 2025

Osmind Bolsters Leadership Team to Transform Psychiatric Practice Management

June 5, 2025

Osmind Partners with Otsuka Precision Health to Transform Precision Psychiatry

May 16, 2025

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs

April 21, 2025

‍Osmind Appoints Dr. William Sauvé as Chief Medical Officer to Advance Interventional Psychiatric Care

January 16, 2025

Osmind and UBC partner to Advance Mental Health Treatment Through REMS Innovation

October 29, 2024

Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

May 2, 2024

Osmind Reimagines Insurance Reimbursement for Psychiatric Clinicians, Expanding Patient Access to Mental Health Care

October 24, 2023

Aledade, Mark Cuban's drug company and a handful of others are public benefit corporations. Could it be the Rx to improve healthcare?

February 3, 2023

OSMIND: BUILDING A PLATFORM FOR BREAKTHROUGH MENTAL HEALTH

January 27, 2023

Innovative mental healthcare practices are hampered by access challenges, administrative burdens

December 16, 2022

Lucia Huang and Jimmy Qian, Osmind — Founder Story

October 11, 2022

Poets & Quants’ Most Successful MBA Startups Of 2022

October 10, 2022

Lucia Huang: Destigmatizing Mental Health

September 28, 2022

Osmind launches integrated virtual visits, expanding care options for in-demand mental health clinicians

September 15, 2022

Osmind rolls out integrated virtual visits

September 15, 2022

Osmind EHR integrates Zoom for psychiatry telehealth

September 15, 2022

The 21 most promising healthtech startups of 2022, according to top VCs

September 6, 2022

Osmind Recognized as a Y Combinator Top Company

August 23, 2022

Scouting Report-Osmind: An EHR for Doctors and Researchers Targeting Treatment-Resistant Depression

May 22, 2022

Osmind banks $40M to scale up EHR for mental health providers with a focus on psychedelic, ketamine therapies

May 16, 2022

Osmind Raises $40M for Breakthrough Mental Health Therapies

May 11, 2022

Mental health record specialist Osmind raises $40 million

May 11, 2022

Osmind Raises $40M to Scale Mental Health Treatment, Research EHR

May 11, 2022

Osmind Raises $40M in Series B Funding

May 10, 2022

A Beautiful (Os)mind

May 10, 2022

Our Investment in Osmind

May 10, 2022

Osmind scores $40M investment to aid in mental health research and treatment

May 10, 2022

Osmind Secures $40M to Expand Mental Health EHR Platform

May 10, 2022

Osmind raises $40M for emerging mental health treatment EHR and more digital health fundings

May 10, 2022

Osmind raises $40 million to expand electronic records for mental health

May 10, 2022

Osmind Raises $40M Series B Round Led by DFJ Growth to Expand Platform for Breakthrough Mental Health Research and Treatment

May 10, 2022

Gold House launches venture fund to back API founders

April 19, 2022

7 hottest psychedelics startups that are set to take off in 2022 ‍

March 29, 2022

Psychiatrist Vs. Psychologist: Differences and How to Choose ‍

March 24, 2022

Psychedelic Drug MDMA Shows Promise as Treatment for PTSD ‍

March 22, 2022

Ketamine Intravenous Therapy Shown to Improve Depression, Reduce Suicidal Ideation ‍

January 26, 2022

New Treatment Update: FDA Approves Non-psychedelic Ketamine for Clinical Trials

January 24, 2022

Osmind Announces Appointment of Brent Saunders, Pharma Veteran and Former CEO of Allergan, to Board of Directors ‍

January 21, 2022

Study: Intravenous Ketamine Is a Rapid and Robust Treatment for Depression

January 12, 2022

Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression ‍

January 11, 2022

Osmind Expands Senior Leadership Team With Addition of Chief Growth Officer and Scientific Advisory Board Members ‍

January 4, 2022

The famed startup accelerator Y Combinator is wading into the $100 billion psychedelics industry. Here's how 3 psychedelics firms got into the program. ‍

December 13, 2021

Osmind named to the 2021 CB Insights Digital Health 150 - list of most innovative digital health startups

December 8, 2021

Forbes 30 Under 30

December 1, 2021

Capital ideas: Setting the stage

November 1, 2021

VCs name the top 15 startups in the psychedelics industry ‍

August 2, 2021

InnovationRx: 50 Over 50; Plus Delta Is Dominant

July 7, 2021

Osmind Closes $15 Million Series A Round to Help Clinicians and Researchers Bring Innovative Mental Health Treatments to More Patients

July 2, 2021

This Startup Just Raised $15 Million To Make Better Software For Psychiatrists ‍

July 1, 2021

Osmind Closes $15 Million Series A Round to Help Clinicians and Researchers Bring Innovative Mental Health Treatments to More Patients ‍‍

July 1, 2021

Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction

June 23, 2021

New Study Asks Clinicians to Help Shape the Future Of Psychedelic Integration Therapy ‍

June 21, 2021

Osmind: Presenting the Next Generation of Digital Therapeutics for the Psychedelic Industry

May 25, 2021

Dr. Robin Carhart-Harris Joins Osmind as a Scientific Advisor

February 4, 2021

Ketamine Taskforce for Access to Safe Care and Insurance Coverage Launches, Offering Hope to Chronic Pain and Mental Health Patients ‍

February 1, 2021

Osmind Raises $2M Seed Round to Revolutionize Mental Health by Empowering Mental Health Patients, Clinicians, and Researchers ‍

October 14, 2020

Exclusive: Osmind Inks $2M To Improve Care Delivery, Treatment For Mental Health ‍

October 14, 2020

Osmind wants to refine drug therapies for mental health treatments‍

September 14, 2020

Here are all of the Bay Area startups from Y Combinator Demo Day 2 ‍

August 26, 2020

Here are the 94 companies from Y Combinator’s Summer 2020 Demo Day 2 ‍

August 25, 2020

Osmind pitches clinical management and data analysis for mental health practices using psychedelics ‍

August 23, 2020

Mental Health America Connect - Osmind Online Community

June 1, 2020

View older posts

Solutions

CliniciansLife Sciences

Products

Osmind OneOsmind Care NetworkOsmind 360

Osmind

AboutCareersNewsResearch

Connect

Psychiatry CollectiveLinkedinInstagramYouTubeX

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255 or 988.

Osmind © 2026  All Rights Reserved.

Privacy PolicyTerms of Service